KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Debt (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Total Debt data on record, last reported at $449.8 million in Q4 2025.

  • For Q4 2025, Total Debt fell 35.72% year-over-year to $449.8 million; the TTM value through Dec 2025 reached $449.8 million, down 35.72%, while the annual FY2025 figure was $449.8 million, 35.72% down from the prior year.
  • Total Debt reached $449.8 million in Q4 2025 per IDXX's latest filing, down from $524.8 million in the prior quarter.
  • Across five years, Total Debt topped out at $1.4 billion in Q2 2022 and bottomed at $449.8 million in Q4 2025.
  • Average Total Debt over 5 years is $782.2 million, with a median of $771.1 million recorded in 2022.
  • Peak YoY movement for Total Debt: surged 52.36% in 2022, then crashed 35.72% in 2025.
  • A 5-year view of Total Debt shows it stood at $850.2 million in 2021, then rose by 11.08% to $944.4 million in 2022, then decreased by 26.1% to $697.9 million in 2023, then rose by 0.27% to $699.8 million in 2024, then plummeted by 35.72% to $449.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Debt were $449.8 million in Q4 2025, $524.8 million in Q3 2025, and $524.8 million in Q2 2025.